AU2003294217A1 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Human polypeptides encoded by polynucleotides and methods of their use

Info

Publication number: AU2003294217A1
Authority: AU; Australia
Prior art keywords: polynucleotides; methods; polypeptides encoded; human polypeptides; human
Prior art date: 2002-08-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003294217A

Other versions

AU2003294217A8 (en

Inventor

Pierre Alvaro Beaurang

Dirk Behrens

Keting Chu

Lin Haishan

Robert Forgan Halenbeck

Kevin Hestir

Min Mei Huang

Srinivas Kothakota

Ernestine Lee

Thomas Linnemann

Kristen Pierce

Yan Wang

Lewis T. Williams

Justin G. P. Wong

Ge Wu

Hongbing Zhang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Five Prime Therapeutics Inc

Original Assignee

Five Prime Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-29

Filing date

2003-08-28

Publication date

2004-05-04

2003-08-28 Application filed by Five Prime Therapeutics Inc filed Critical Five Prime Therapeutics Inc

2004-05-04 Publication of AU2003294217A1 publication Critical patent/AU2003294217A1/en

2004-05-04 Publication of AU2003294217A8 publication Critical patent/AU2003294217A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU2003294217A 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use Abandoned AU2003294217A1 (en)

Applications Claiming Priority (136)

Application Number	Priority Date	Filing Date	Title
US40657902P	2002-08-29	2002-08-29
US40664602P	2002-08-29	2002-08-29
US40658802P	2002-08-29	2002-08-29
US40660802P	2002-08-29	2002-08-29
US40664002P	2002-08-29	2002-08-29
US40665302P	2002-08-29	2002-08-29
US40666602P	2002-08-29	2002-08-29
US40664202P	2002-08-29	2002-08-29
US40665502P	2002-08-29	2002-08-29
US40658502P	2002-08-29	2002-08-29
US40661202P	2002-08-29	2002-08-29
US40661602P	2002-08-29	2002-08-29
US40661102P	2002-08-29	2002-08-29
US40657602P	2002-08-29	2002-08-29
US60/406,655		2002-08-29
US60/406,588		2002-08-29
US60/406,616		2002-08-29
US60/406,579		2002-08-29
US60/406,585		2002-08-29
US60/406,666		2002-08-29
US60/406,653		2002-08-29
US60/406,642		2002-08-29
US60/406,646		2002-08-29
US60/406,611		2002-08-29
US60/406,576		2002-08-29
US60/406,612		2002-08-29
US60/406,608		2002-08-29
US60/406,640		2002-08-29
US60/411,032		2002-09-16
US41103702P	2002-09-17	2002-09-17
US41102202P	2002-09-17	2002-09-17
US41102402P	2002-09-17	2002-09-17
US41104502P	2002-09-17	2002-09-17
US41095802P	2002-09-17	2002-09-17
US41104602P	2002-09-17	2002-09-17
US41094702P	2002-09-17	2002-09-17
US41095902P	2002-09-17	2002-09-17
US41094902P	2002-09-17	2002-09-17
US41105202P	2002-09-17	2002-09-17
US41095702P	2002-09-17	2002-09-17
US41096202P	2002-09-17	2002-09-17
US41107302P	2002-09-17	2002-09-17
US41094602P	2002-09-17	2002-09-17
US41096102P	2002-09-17	2002-09-17
US41110102P	2002-09-17	2002-09-17
US41096002P	2002-09-17	2002-09-17
US41101902P	2002-09-17	2002-09-17
US41104802P	2002-09-17	2002-09-17
US41104102P	2002-09-17	2002-09-17
US41103502P	2002-09-17	2002-09-17
US41095302P	2002-09-17	2002-09-17
US41105502P	2002-09-17	2002-09-17
US41111102P	2002-09-17	2002-09-17
US41108202P	2002-09-17	2002-09-17
US41102302P	2002-09-17	2002-09-17
US41094802P	2002-09-17	2002-09-17
US60/411,052		2002-09-17
US60/410,960		2002-09-17
US60/410,947		2002-09-17
US60/411,101		2002-09-17
US60/410,949		2002-09-17
US60/411,035		2002-09-17
US60/410,953		2002-09-17
US60/410,961		2002-09-17
US60/411,111		2002-09-17
US60/411,019		2002-09-17
US60/411,037		2002-09-17
US60/411,046		2002-09-17
US60/411,023		2002-09-17
US60/410,958		2002-09-17
US60/411,041		2002-09-17
US60/410,946		2002-09-17
US60/411,073		2002-09-17
US60/410,957		2002-09-17
US60/411,048		2002-09-17
US60/410,948		2002-09-17
US60/411,082		2002-09-17
US60/411,045		2002-09-17
US60/411,055		2002-09-17
US60/411,022		2002-09-17
US60/410,959		2002-09-17
US60/410,962		2002-09-17
US60/411,024		2002-09-17
US46373203P	2003-04-18	2003-04-18
US46371603P	2003-04-18	2003-04-18
US46370003P	2003-04-18	2003-04-18
US46370803P	2003-04-18	2003-04-18
US60/463,716		2003-04-18
US60/463,700		2003-04-18
US60/463,732		2003-04-18
US60/463,708		2003-04-18
US46720303P	2003-05-02	2003-05-02
US46723003P	2003-05-02	2003-05-02
US46719903P	2003-05-02	2003-05-02
US46720103P	2003-05-02	2003-05-02
US60/467,199		2003-05-02
US60/467,203		2003-05-02
US60/467,201		2003-05-02
US60/467,230		2003-05-02
US47133603P	2003-05-19	2003-05-19
US47130603P	2003-05-19	2003-05-19
US60/471,306		2003-05-19
US60/471,336		2003-05-19
US47243003P	2003-05-22	2003-05-22
US47242003P	2003-05-22	2003-05-22
US60/472,430		2003-05-22
US60/472,420		2003-05-22
US47664103P	2003-06-09	2003-06-09
US47660903P	2003-06-09	2003-06-09
US60/476,609		2003-06-09
US60/476,641		2003-06-09
US48532503P	2003-07-08	2003-07-08
US48522303P	2003-07-08	2003-07-08
US48522403P	2003-07-08	2003-07-08
US48521803P	2003-07-08	2003-07-08
US60/485,224		2003-07-08
US60/485,223		2003-07-08
US60/485,218		2003-07-08
US60/485,325		2003-07-08
US48648003P	2003-07-14	2003-07-14
US48644603P	2003-07-14	2003-07-14
US60/486,480		2003-07-14
US60/486,446		2003-07-14
US48696003P	2003-07-15	2003-07-15
US48689103P	2003-07-15	2003-07-15
US60/486,891		2003-07-15
US60/486,960		2003-07-15
US49357303P	2003-08-08	2003-08-08
US49334103P	2003-08-08	2003-08-08
US49357703P	2003-08-08	2003-08-08
US49337003P	2003-08-08	2003-08-08
US60/493,370		2003-08-08
US60/493,341		2003-08-08
US60/493,573		2003-08-08
US60/493,577		2003-08-08
PCT/US2003/026780 WO2004035732A2 (en)	2002-08-29	2003-08-28	Human polypeptides encoded by polynucleotides and methods of their use

Publications (2)

Publication Number	Publication Date
AU2003294217A1 true AU2003294217A1 (en)	2004-05-04
AU2003294217A8 AU2003294217A8 (en)	2004-05-04

Family

ID=37714949

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003294217A Abandoned AU2003294217A1 (en)	2002-08-29	2003-08-28	Human polypeptides encoded by polynucleotides and methods of their use

Country Status (2)

Country	Link
AU (1)	AU2003294217A1 (en)
WO (1)	WO2004035732A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005229434B2 (en) *	2004-03-30	2010-09-30	Nsgene A/S	Therapeutic use of a growth factor, NsG33

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0401730D0 (en)	2004-01-27	2004-03-03	Bioxell Spa	Diagnosis method
WO2005101004A2 (en) *	2004-04-13	2005-10-27	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1)
BRPI0513329A (en)	2004-07-12	2008-05-13	Cropdesign Nv	method for improving plant growth characteristics, plants, construction, method for producing a transgenic plant, transgenic plant, collectible parts of a plant, products, and use of a yippee-like gene or nucleic acid or variant thereof or use of a yippee-like or homologous polypeptide thereof
EP1627922A1 (en)	2004-08-18	2006-02-22	Sanofi-Aventis Deutschland GmbH	Method of screening for a carnitine transporter agonist or antagonist and its uses
EP1885755A4 (en)	2005-05-05	2009-07-29	Univ Duke	TREATMENTS OF AUTOIMMUNE DISEASES BY ANTI-CD19 ANTIBODIES
US7354904B2 (en) *	2005-12-08	2008-04-08	The United States Of America As Represented By The Secretary Of Agriculture	Bacteriocin inducer peptides
CA2656192C (en)	2006-06-30	2016-05-03	Ambit Biosciences Corporation	Detectable nucleic acid tag
WO2008097439A2 (en) *	2007-02-07	2008-08-14	The Trustees Of The University Of Pennsylvania	Anti-autoimmune antibodies for treatment of pemphigus
UA100127C2 (en)	2007-08-20	2012-11-26	Онкотерапи Саенс, Инк.	Peptide cdh3 and drug containing it
GB0803352D0 (en) *	2008-02-22	2008-04-02	Ntnu Technology Transfer As	Oligopeptidic compounds and uses thereof
WO2010009732A1 (en)	2008-07-24	2010-01-28	Nsgene A/S	Therapeutic use of a growth factor, metrnl
TW201008574A (en)	2008-08-19	2010-03-01	Oncotherapy Science Inc	INHBB epitope peptides and vaccines containing the same
WO2010124157A1 (en)	2009-04-24	2010-10-28	Ambit Biosciences Corporation	Cellular assay employing detectable protein
WO2011063128A1 (en)	2009-11-18	2011-05-26	Affinergy, Inc.	Implantable bone graft materials
ES2584068T3 (en)	2010-10-01	2016-09-23	Nsgene A/S	Use of meteorine to treat allodynia, hyperalgesia, spontaneous pain and phantom pain
WO2013034157A1 (en)	2011-09-05	2013-03-14	Nsgene A/S	Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain
WO2014071200A1 (en) *	2012-11-02	2014-05-08	The Regents Of The University Of Colorado, A Body Corporate	Beta blocker responder status assays and related materials and methods
WO2014141064A1 (en)	2013-03-13	2014-09-18	Novartis Ag	Notch2 binding molecules for treating respiratory diseases
EP3604331A1 (en)	2013-12-20	2020-02-05	Novartis AG	Novel eukaryotic cells and methods for recombinantly expressing a product of interest
CA2934412C (en) *	2013-12-20	2024-02-20	Novartis Ag	Novel eukaryotic cells and methods for recombinantly expressing a product of interest
EP2899205A1 (en) *	2014-01-23	2015-07-29	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Interaction of Draxin and y-Netrins
WO2016073845A1 (en) *	2014-11-07	2016-05-12	Igenica Biotherapeutics, Inc.	Anti-cd39 antibodies and uses thereof
US20240076327A1 (en) *	2020-12-21	2024-03-07	Syngenta Crop Protection Ag	Pesticidal hexatoxin polypeptides and methods of use thereof

2003
- 2003-08-28 AU AU2003294217A patent/AU2003294217A1/en not_active Abandoned
- 2003-08-28 WO PCT/US2003/026780 patent/WO2004035732A2/en not_active Ceased

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005229434B2 (en) *	2004-03-30	2010-09-30	Nsgene A/S	Therapeutic use of a growth factor, NsG33

Also Published As

Publication number	Publication date
WO2004035732A2 (en)	2004-04-29
AU2003294217A8 (en)	2004-05-04
WO2004035732A3 (en)	2006-01-26

Publication	Publication Date	Title
AU2003294217A1 (en)	2004-05-04	Human polypeptides encoded by polynucleotides and methods of their use
EP1576169A4 (en)	2008-07-16	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003295343A1 (en)	2004-04-23	Uses of human zven proteins and polynucleotides
AU2003298606A1 (en)	2004-05-13	Human polypeptides encoded by polynucleotides and methods of their use
AU2003217956A1 (en)	2003-09-29	Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2002334781A1 (en)	2003-04-22	Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003265787A1 (en)	2004-03-19	Methods of use for novel human polypeptides encoded by polynucleotides
EP1549671A4 (en)	2006-11-22	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002309646A1 (en)	2002-11-18	Novel human proteins, polynucleotides encoding them and methods of using the same
PL375356A1 (en)	2005-11-28	Claudin polypeptides, polynucleotides, and methods of making and use thereof
WO2003023002A9 (en)	2013-11-07	Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002303232A1 (en)	2002-10-21	Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003294236A1 (en)	2004-05-25	Methods of use for novel human polypeptides encoded by polynucleotides
AU2003284967A1 (en)	2004-06-15	Novel mouse polypeptides encoded by polynucleotides and methods of their use
WO2003060149A9 (en)	2010-08-05	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003304034A1 (en)	2004-11-01	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003270424A1 (en)	2004-03-29	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002322404A1 (en)	2003-01-21	Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002254163A1 (en)	2002-09-24	Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002345407A1 (en)	2004-01-19	Human cervical cancer 5 protooncogene and protein encoded therein
EP1587829A4 (en)	2006-05-31	Human protooncogene and protein encoded therein
EP1539807A4 (en)	2006-09-06	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1513864A4 (en)	2006-04-05	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004061073A9 (en)	2013-10-31	Novel human proteins, polynucleotides encoding them and methods of using the same
EP1551440A4 (en)	2009-07-15	Uses of human zven proteins and polynucleotides

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

AU2003294217A1 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (136)

Publications (2)

Family

ID=37714949

Family Applications (1)

Country Status (2)

Cited By (1)

Families Citing this family (23)

Cited By (1)

Also Published As

Similar Documents

Legal Events